Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

SP-A2 contributes to miRNA-mediated sex differences in response to oxidative stress: pro-inflammatory, anti-apoptotic, and anti-oxidant pathways are involved.

Noutsios GT, Thorenoor N, Zhang X, Phelps DS, Umstead TM, Durrani F, Floros J.

Biol Sex Differ. 2017 Dec 4;8(1):37. doi: 10.1186/s13293-017-0158-2.

2.

Highly Effective Dual-Function Near-Infrared (NIR) Photosensitizer for Fluorescence Imaging and Photodynamic Therapy (PDT) of Cancer.

Patel N, Pera P, Joshi P, Dukh M, Tabaczynski WA, Siters KE, Kryman M, Cheruku RR, Durrani F, Missert JR, Watson R, Ohulchanskyy TY, Tracy EC, Baumann H, Pandey RK.

J Med Chem. 2016 Nov 10;59(21):9774-9787. Epub 2016 Oct 31.

PMID:
27749069
3.

Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).

James NS, Joshi P, Ohulchanskyy TY, Chen Y, Tabaczynski W, Durrani F, Shibata M, Pandey RK.

Eur J Med Chem. 2016 Oct 21;122:770-785. doi: 10.1016/j.ejmech.2016.06.045. Epub 2016 Jun 29.

4.

Expression and rapid purification of recombinant biologically active ovine growth hormone with DsbA targeting to Escherichia coli inner membrane.

Durrani FG, Gul R, Sadaf S, Akhtar MW.

Appl Microbiol Biotechnol. 2015 Aug;99(16):6791-801. doi: 10.1007/s00253-015-6751-6. Epub 2015 Jun 28.

PMID:
26124068
5.

Hyperplastic cardiac sarcoma recurrence.

Shariff MA, Abreu JA, Durrani F, Daniele E, Bowman KC, Sadel S, Asgarian KT, McGinn JT Jr, Nabagiez JP.

Case Rep Surg. 2015;2015:132328. doi: 10.1155/2015/132328. Epub 2015 Feb 15.

6.

Myeloperoxidase level around dental implants as an indicator of an inflammatory process.

Durrani F, Singh R.

Indian J Dent. 2015 Jan-Mar;6(1):2-6. doi: 10.4103/0975-962X.151688.

7.

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models.

Cao S, Durrani FA, Tóth K, Rustum YM.

Br J Cancer. 2014 Apr 2;110(7):1733-43. doi: 10.1038/bjc.2014.85. Epub 2014 Mar 11.

8.

Microsurgical aesthetic treatment of gingival fenestration by a coronally repositioned partial thickness graft: a case report.

Patel PV, Kumar N, Durrani F.

J Clin Diagn Res. 2013 Nov;7(11):2649-50. doi: 10.7860/JCDR/2013/5860.3640. Epub 2013 Nov 10.

9.

Etiology and outcome of severe community acquired pneumonia in immunocompetent adults.

Khawaja A, Zubairi AB, Durrani FK, Zafar A.

BMC Infect Dis. 2013 Feb 20;13:94. doi: 10.1186/1471-2334-13-94.

10.
11.

Gonadal hormones and oxidative stress interaction differentially affects survival of male and female mice after lung Klebsiella pneumoniae infection.

Durrani F, Phelps DS, Weisz J, Silveyra P, Hu S, Mikerov AN, Floros J.

Exp Lung Res. 2012 May;38(4):165-72. doi: 10.3109/01902148.2011.654045. Epub 2012 Mar 6.

12.

Impact of sex and ozone exposure on the course of pneumonia in wild type and SP-A (-/-) mice.

Mikerov AN, Hu S, Durrani F, Gan X, Wang G, Umstead TM, Phelps DS, Floros J.

Microb Pathog. 2012 Apr;52(4):239-49. doi: 10.1016/j.micpath.2012.01.005. Epub 2012 Jan 20.

13.

Ugt1a is required for the protective effect of selenium against irinotecan-induced toxicity.

Cao S, Durrani FA, Rustum YM, Yu YE.

Cancer Chemother Pharmacol. 2012 Apr;69(4):1107-11. doi: 10.1007/s00280-011-1820-8. Epub 2012 Jan 12.

14.

Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulation.

Azrak RG, Cao S, Durrani FA, Toth K, Bhattacharya A, Rustum YM.

Cancer Lett. 2011 Dec 8;311(2):219-29. doi: 10.1016/j.canlet.2011.07.023. Epub 2011 Aug 6.

15.

Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts.

Cao S, Durrani FA, Toth K, Rustum YM, Seshadri M.

Oral Oncol. 2011 Jun;47(6):459-66. doi: 10.1016/j.oraloncology.2011.04.001. Epub 2011 May 6.

16.

Immunomodulatory and hepatoprotective role of feed-added Berberis lycium in broiler chicks.

Chand N, Durrani FR, Ahmad S, Khan A.

J Sci Food Agric. 2011 Aug 15;91(10):1737-45. doi: 10.1002/jsfa.4399. Epub 2011 Apr 7.

PMID:
21480270
17.

Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts.

Chintala S, Tóth K, Yin MB, Bhattacharya A, Smith SB, Ola MS, Cao S, Durrani FA, Zinia TR, Dean R, Slocum HK, Rustum YM.

Chemotherapy. 2010;56(3):223-33. doi: 10.1159/000316334. Epub 2010 Jun 11.

18.

Architectural heterogeneity in tumors caused by differentiation alters intratumoral drug distribution and affects therapeutic synergy of antiangiogenic organoselenium compound.

Rustum YM, Tóth K, Seshadri M, Sen A, Durrani FA, Stott E, Morrison CD, Cao S, Bhattacharya A.

J Oncol. 2010;2010:396286. doi: 10.1155/2010/396286. Epub 2010 Apr 27.

19.

Chronic fungal sinusitis leading to disastrous cerebral aspergillosis: a case report.

Popalzai MJ, Kushawaha A, Mobarakai N, Asrar R, Durrani F.

Cases J. 2009 Dec 31;2:9406. doi: 10.1186/1757-1626-2-9406.

20.

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.

Chintala S, Tóth K, Cao S, Durrani FA, Vaughan MM, Jensen RL, Rustum YM.

Cancer Chemother Pharmacol. 2010 Oct;66(5):899-911. doi: 10.1007/s00280-009-1238-8. Epub 2010 Jan 12.

21.

Isolated Hypoglossal Nerve Palsy due to Infected Impacted Tooth.

Durrani F, Singh R.

Case Rep Med. 2009;2009:231947. doi: 10.1155/2009/231947. Epub 2009 Sep 14.

22.

Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor.

Bhattacharya A, Tóth K, Sen A, Seshadri M, Cao S, Durrani FA, Faber E, Repasky EA, Rustum YM.

Clin Colorectal Cancer. 2009 Jul;8(3):155-62. doi: 10.3816/CCC.2009.n.025.

23.

Intraosseous follicular adenomatoid odontogenic tumour-a case report.

Durrani F, Singh R.

Int J Dent. 2009;2009:597483. doi: 10.1155/2009/597483. Epub 2010 Mar 11.

24.

Effect of different levels of feed added black seed (Nigella sativa L.) on the performance of broiler chicks.

Durrani FR, Chand N, Zaka K, Sultan A, Khattak FM, Durrani Z.

Pak J Biol Sci. 2007 Nov 15;10(22):4164-7.

PMID:
19090301
26.

Efficacy of aniseed extract as immune stimulant and growth promoter in broiler chicks.

Durrani FR, Sultan A, Ahmed S, Chand N, Khattak FM, Durrani Z.

Pak J Biol Sci. 2007 Oct 15;10(20):3718-21.

PMID:
19093489
27.

Effect of wild mint (Mentha longifolia) infusion on the over all performance of broiler chicks.

Durrani FR, Sultan A, Marri ML, Chand N, Durrani Z.

Pak J Biol Sci. 2007 Apr 1;10(7):1130-3.

PMID:
19070065
28.

Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil.

Javle MM, Cao S, Durrani FA, Pendyala L, Lawrence DD, Smith PF, Creaven PJ, Noel DC, Iyer RV, Rustum YM.

Clin Cancer Res. 2007 Feb 1;13(3):965-71.

29.

Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent.

Azrak RG, Cao S, Pendyala L, Durrani FA, Fakih M, Combs GF Jr, Prey J, Smith PF, Rustum YM.

Biochem Pharmacol. 2007 May 1;73(9):1280-7. Epub 2006 Dec 22.

30.

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.

Cao S, Bhattacharya A, Durrani FA, Fakih M.

Expert Opin Pharmacother. 2006 Apr;7(6):687-703. Review.

PMID:
16556086
32.
33.

Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors.

Azrak RG, Yu J, Pendyala L, Smith PF, Cao S, Li X, Shannon WD, Durrani FA, McLeod HL, Rustum YM.

Mol Cancer Ther. 2005 May;4(5):843-54.

34.

Synergistic antitumor activity of capecitabine in combination with irinotecan.

Cao S, Durrani FA, Rustum YM.

Clin Colorectal Cancer. 2005 Jan;4(5):336-43.

PMID:
15663838
35.
36.

Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison.

Antony S, Kohlhagen G, Agama K, Jayaraman M, Cao S, Durrani FA, Rustum YM, Cushman M, Pommier Y.

Mol Pharmacol. 2005 Feb;67(2):523-30. Epub 2004 Nov 5.

38.
39.

Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts.

Azrak RG, Cao S, Slocum HK, Tóth K, Durrani FA, Yin MB, Pendyala L, Zhang W, McLeod HL, Rustum YM.

Clin Cancer Res. 2004 Feb 1;10(3):1121-9.

40.
41.

Haemopoietic growth factor GM-CSF for aplastic anaemia in children.

Khan MA, Hameed A, Tahir M, Gandapur AJ, Rehman Hu, Durrani FM, Ahmad A.

Lancet. 1995 Jan 21;345(8943):199. No abstract available.

PMID:
7823700
42.
44.

Evaluation of a new, shorter method of administration of adrenergic aerosols in the treatment of asthma.

Durrani FK, Richards W, Church JA, Roberts MJ, Keens TG.

Ann Allergy. 1988 Aug;61(2):147-50.

PMID:
3400901
45.

Cyanosis and unrecognised atrial septal defect in children.

Durrani F, Hope RR.

N Z Med J. 1975 May 28;81(540):481-2.

PMID:
1057094
46.

Persistent left fifth aortic arch in man. Report of two cases.

Izukawa T, Scott ME, Durrani F, Moes CA.

Br Heart J. 1973 Nov;35(11):1190-5. No abstract available.

Supplemental Content

Loading ...
Support Center